Tag Archives: UVC Disinfection Technology

Path03Gen Is Taking a Step In the Right Direction to Reduce Healthcare-Associated Infections (HAI’s)

Amazing research and developments are taking place all across the globe.

In St. Petersburg, Florida there is an organization dedicated in fighting  harmful pathogens and the St. Pete Catalyst’s Journalist Margie Manning had the following to report on the “Green Earth Medical Solutions” technology company:

Green Earth Medical Solutions developed technology that kills germs on the bottom of shoes, which often are overlooked as a source for bacteria, virus and other disease-causing microorganisms.

The company’s PathO3Gen sanitizing stations combine UVC, a type of ultraviolet light, and ozone, to sanitize shoes. Anyone entering a healthcare facility or a critical care area steps on the station and waits for about six seconds. When they step off, 99.9 percent of the deadly pathogens have been eliminated, said chief operating officer Scott Beal.

Healthcare acquired infections, or HAIs, cause about 100,000 deaths every year, according to the Centers for Disease Control and Prevention. There’s been a lot of attention paid to infection control in healthcare, most of it focused on hand washing and cleaning high-touch surfaces. A 2017 clinical study showed 77 percent of the soles of shoes walking into a hospital contained superbugs such as MRSA and C. difficile, or a combination of the two.

“Initially, clinicians said ‘we don’t operate on the floors, those are not areas of concern,’” Beal said. “But the infection control community and stakeholders have been coming out with more and more published credible studies that say what is tracked in on the floor is getting airborne and aerosolized, and makes it to high-touch areas, which then cause HAIs.”

Reducing pathogens tracked in by shoes also increases the efficacy of other sanitizing methods, because the building is not being overrun by germs, Beal said.

Hospitals have financial reasons to reduce hospital-acquired infections. Beginning in 2015, federal reimbursements to hospitals were directly affected by their HAI rates.

AdventHealth Connerton, an acute-care specialty hospital in Pasco County, is testing the technology.

“The sanitizing stations allow us to establish new protocols that proactively prevent infections to ensure the best possible outcomes for patients while they’re in our care,” Debi Martoccio, chief operating officer at AdventHealth Connerton, said in a statement.

With any new technology, gaining traction and changing minds are tough to do, Beal said.

“It’s important to have someone the size and scope and reputation of AdventHealth that sees the benefit of what we are trying to accomplish,” he said.

There also are foot sanitizing stations at Cypress Creek Assisted Living in Sun City Center.

There are competitors that use UVC to disinfect shoes, Beal said. None of those companies combine UVC with ozone, a combination initially created by Asher Gil, an Israeli aeronautical engineer. Gil tested his combination of UVC and ozone at University of South Florida. Gil was bought out about three years ago by his partners, who further developed the technology and ran clinical tests. The product went to market in the fourth quarter of 2018.

Those initial owners and one outside investor have provided the capital for Green Earth Medical, now in its second round of fundraising, Beal said.

The company is headquartered in downtown St. Petersburg. It has four full-time employees, and contracts with distributors to market the sanitizing stations. There are about 25 to 30 representatives in the field marketing the product, and the company is in the early stages of talks with more healthcare facilities, as well as clean rooms and labs, Beal said.

The sanitizing stations are the only product right now, but other products are in the process of being patented, he said. He expects to ramp up development on those once the company gains traction.

“We are out trying to market, educate, change perceptions and shift the paradigms that exist around infection controls,” Beal said. “Our goal is to reduce bioburden in every facility that has an immune-compromised population.”

RESOURCE;  https://stpetecatalyst.com/st-pete-tech-company-steps-into-hospital-safety/

.

ABC ACTION NEWS INTERVIEW WITH DEBI MORTOCCIO, COO – ADVENTHEALTH  CONNERTON

 

 

Multidisciplinary Program Duke University Medical Center Included UVC Disinfection Technology To Reduce Hospital-Acquired Infections Including CDI

IN THE NEWS………………..

A new manuscript has been accepted by the Journal of the American College of Surgeons which examines C. diff in adult surgical patients. The paper, “Multidisciplinary Approach and Clostridium difficile Infection in Adult Surgical Patients,” discusses the multidisciplinary program that Duke University Medical Center implemented to reduce its C. diff rate.

In 2017, Duke University Medical Center was identified as a “High Outlier” for postoperative C. diff infections in the American College of Surgeons NSQIP semi-annual report with .4 percent cases per year with an increased risk in morbidity and mortality. To address the issue,

“The Department of Surgery initiated a CDI Task Force with representation from Surgery, Infectious Disease, Pharmacy and Performance Services to analyze available data, identify opportunities for improvement and implement strategies to reduce CDI,” the manuscript states.

Strategies to reduce CDI included antimicrobial stewardship optimization, increased use of Tru-D SmartUVC for terminal cleaning of CDI patient rooms, increased hand hygiene and PPE signage as well as monitoring in high-risk CDI areas, improved diagnostic stewardship by an electronic best practice advisory to reduce inappropriate CDI testing, education through surgical grand rounds and routine data feedback via NSQIP and NHSN CDI reports.

Using these strategies, observed rate of C. diff decreased from 1.27 percent in 2016 to 0.91 percent in 2017, a 28 percent decrease.

“Reducing hospital-acquired infections, especially C. diff, takes a multidisciplinary approach and a commitment to numerous infection prevention protocols,” Alice Brewer, MPH, CIC, Director of Clinical Affairs for Tru-D SmartUVC, said.

As one of the strategies, “We reviewed the terminal cleaning policies for rooms occupied by patients with known CDI once they were discharged from the hospital,” the authors stated. “Additionally, the success at eliminating C. difficile through the established terminal cleans was verified through an auditing process. However, the audit demonstrated that there was variability and ineffective cleaning practices within the hospital system. These deficiencies were largely due to lack of Environmental Services staff and staff trained in Tru-D technology.”

The conclusion provided a basis for requesting the hiring and training of additional Environmental Services staff and “expanded training for terminal cleans was used for the Tru-D technology system, a system which uses an ultraviolet light cleaning system to denature the spores of C. difficile. This provided more effective terminal cleaning.”

By training five additional Tru-D operators, the facility went from using Tru-D on 30 percent of C. diff rooms to 100 percent of C. diff rooms. “Appropriately trained Tru-D technicians increased in number following the initiative from two in 2017 to seven in 2019.

This increase in technicians allowed for an increase in terminal cleans by Tru-D Ultraviolet therapy from 30 percent in March 2017 to 100 percent in September 2018,” the manuscript states.

Validated by multiple studies including the only randomized clinical trial on UVC disinfection, Tru-D has been proven to be a chemical-free and environmentally-friendly way of providing thorough room disinfection. UVC is a type of energy that is invisible to the human eye. Its wavelengths are between 200 and 300 nanometers, making them germicidal – meaning they are capable of inactivating microorganisms, such as bacteria, viruses and protozoa.

“It has been proven that increased utilization of Tru-D and UVC disinfection technology correlates to a reduction in hospital-acquired infections, including C. diff,” Brewer said. “By training additional staff in the operation of Tru-D, Duke was able to achieve 100 percent utilization, which helped to contribute to the 28 percent reduction in C. diff infections.”

To Read Article In Its Entirety – Please Click On the Following Link To Be Redirected:

https://www.prnewswire.com/news-releases/duke-university-medical-center-reduces-postoperative-c-diff-rates-with-bundled-approach-300800682.html